Complimenti.....Sei entrato nel piu' completo Portale sulle Medicine Alternative, Biologico  Naturali e Spirituali - la Guida alla Salute Naturale - Leggi, Studia, Pratica e starai in Perfetta  Salute, senza Farmaci ne' Vaccini

GUIDA  alla  SALUTE con la Natura

"Medicina Alternativa"   per  CORPO  e   SPIRITO
Alternative Medicine"
  for  BODY  and SPIRIT


Bibliografia su AIDS e medicine Complementari 

Gli sconvolgenti documenti ufficiali, alcuni dei quali totalmente inediti in Italia, che provano la truffa dell'Hiv-Aids.
Fatti a me ben noti, da giornalista investigativo e dati per scontati gia' nel 1983....
Frutto di 3 anni di ricerca intesa e ostacolata di un dottore italiano che, minacciato di morte, è emigrato all'estero. Facciamo girare e diffondiamo il più possibile per favore. Grazie a tutte/i.
L'altra storia dell'Aids + Hiv virus inventato


1.  Elion RA, Cohen C. Complementary medicine and HIV Infection. Primary Care. 1997;24:905-919.
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States,     1990-1997:  results of a follow-up national survey. JAMA. 1998;280:1569-1575.
3. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med.1998;158(20):2257-2264.
4.  Ernst E. Complementary AIDS therapies: the good, the bad, and the ugly. Int J STD AIDS. 1997;8:281-285.
5.  Anderson W, O'Connor BB, MacGregor RR, Schwartz JS. Patient use and assessment of conventional and alternative therapies for HIV infection and AIDS. AIDS. 1993;7:561-566.
6.  Ostrow MJ, Cornelisse PGA, Health KV, et al. Determinants of complementary therapy use in HIV-infected  individuals receiving antiretroviral or anti-opportunistic agents.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:115-120.
7.   Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci. 1978;67:1487-1489.
8.  Heptinstall S, Awang DV, Dawson BA, et al. Parthenolide content and bioactivity of feverfew. Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol. 1992;44:391-395.
9.  Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet. 2000;355(9203):547-548.
10. De Maat MMR, Hoetelmans RMW, van Gorp ECM, de Boer A, Beijnen JH. A potential drug interaction between St. John's wort and nevirapine? First International Workshop on Clinical Pharmacology of HIV Therapy; March 30-31, 2000; Noordwijk, The Netherlands. Abstract 2.8.
11.  Dalvi RR. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett.
12. Laroche M, Choudhri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. In: Program and Abstracts of the Canadian Association for HIV Research Seventh Annual Canadian Conference on HIV/AIDS; April 30 - May 3 1998; Quebec City, PQ, Canada. Abstract 471P.
13. Zima T, Kamenkova L, Janebova M, Buchar E, Crkovska J, Tesar V. The effect of silibinin on experimental cyclosporine nephrotoxicity. Ren Fail. 1998;20:471-479.
14. Racz K, Feher J, Csomos G, Varga I, Kiss R, Glaz E. An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells. J Endocrinol. 1990;124:341-345.
15. Leber HW, Knauff S. Influence of silymarin on drug metabolizing enzymes in rat and man.
Arzneimittelforschung. 1976;26:1603-1605.
16. Henderson GL, Harkey MR, Gershwin ME, et al. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 1999;65:PL209-214.
Kim HJ, Chun YJ, Park JD, et al. Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Med. 1997;63:415-418.
18. Tyler VE. What pharmacists should know about herbal remedies. J Am Pharm Assoc. 1996;NS36:29-37.
19. Natural Medicines Comprehensive database. Stockton, Calif: Therapeutic Research Faculty, 2000.
20. Phillips LG, Nichols MH, King WD. Herbs and HIV: the health food industry's answer. South Med J. 1995;88:911-913.
21.   Snow B. Internet sources of information on alternative medicine. Database. 1998; Aug/Sept:65-73.  

Altra Bilbiografia

1. BLATTNER, W.; GALLO, R. C; and TEMIN, H. M. HIV causes AIDS. Science 241:515­516, 1988.
2. WEBER, J. AIDS and the "guilty" virus. New Scientist, pp. 32­33, May 5, 1988
3. CENTERS FOR DISEASE CONTROL. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36, suppl.: 3S­9S, 1987.
4. LEVINE, A. S. Viruses, immune dysregulation, and oncogenesis: inferences regarding the cause and evolution of AIDS. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KIEN and L. J. LAUBSENSTEIN. New York: Masson, 1984.
5. DUESBERG, P. H. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res. 47:1199 ­ 1220, 1987.
6. DUESBERG, P. H. HIV is not the cause of AIDS. Science 241:514 ­ 17, 1988.
7. DUESBERG, P. H. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc. Natl. Acad. Sci. USA 86:755 ­ 764, 1989.
8. KOVACS, J. A., and MASUR, H. Treatment of opportunistic infections. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELBYE. Philadelphia: Saunders, 1984.
9. PETERMAN, T. A.; STONEBURNER, R. L.; ALLEN, J. R.; et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion­associated infections. JAMA 259:55­58, 1988.
10. BOVE, J. R. The risk of AIDS from transfusion: a current assessment. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KlEN and L. J. LAUBENSTEIN. New York: Masson, 1984.
11. DODD, R. Y., and SANDIER, S. G. Transfusion­associated AIDS. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELSYE. Philadelphia: Saunders, 1984.
12. CENTERS FOR DISEASE CONTROL. Human T­lymphotropic virus type III lymphadenopathy­associated virus antibody testing at alternative sites. MMWR 35:284 ­ 287, 1986.
13. DARROW, W. W.; ECHENBERG, D. F.; JAFFE, H. W.; et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am. J. Public Heallh 77(4):479 ­ 483, 1987.
14. WITKIN, S. S., and SONNABEND, J. Immune responses to spermatozoa in homosexual men. Fertil. Steril 39:337­342, 1983.
15. MAVLIGIT, C,. M.; TALPAZ, M.; HSIA, F. T; et al. Chronic immune stimulation by sperm alloantigens: support for the hypothesis that spermatazoa induce immune dysregulation in homosexual males. JAMA 251(2):237241, 1984.
16. MATHUR, S.; COUST, J.­M.; WILLIAMSON, H. O.; et al. Cross­reactivity of sperm and T­lymphocyte antigens. Am. J. Reprod. Immunol. 1:113­118, 1981.
17. MARCUS, Z. H.; LUNENFELD, B.; WEISSENBERG, R.; and LEWIN, L. M. Immunosuppressant material in human seminal fluid: inhibition of blast transformation and NK activity by seminal fluid patients of a male infertility clinic. Gynecol. Obstet Invest. 23:54­59. 1987.
18. WILLIAMSON, J. D. Semen polyamines in AIDS pathogenesis. Nature 310:103, 1984.
19. NEWELL, G. R.; MANSELL, P. W. A.; SPITZ, M. R.; et al. Volatile nitrites: use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. Am.J. Med. 78:811 ­ 816, 1985.
20. LYNCH, D. W.; MOORMAN, W. J.; BURG, J. R.; et al. Subchronic inhalation toxicity of isobutyl nitrite in BALB/c mice. 1. Systemic toxicity. 11. Immunotoxicity studies. J. Toxicol. Environ. Health 15(6):823 ­ 833, 835­846, 1985.
21. LOTZOVA, E.; SAVARY, C. A.; HERSH, E. M.; et al. Depression of murine natural killer cell cytotoxicity by isobutyl nitrite. Cancer Immunol. Immunother. 17:130­134, 1984.
22. OSTERLOH, J., and OLSON, K. Toxicities of alkyl nitrites. Ann. Intern. Med. 104(5):727, 1986.
23. PIFER, L. L. W.; WANC, Y.­F.; CHIANG, T. M.; et al. Borderline immunode ficiency in male homosexuals: is life­style contributory? South Med. J. 80(6): 687­697, 1987.
24. TARNAWSKI, A., and BATKO, B. Antibiotics and immune processes. Lancet 1:674, 1973.
25. MONSTER, A. M.; LOADHOLDT, C. B.; LEARY, A. C.; and BARNES, M. A. The effect of antibiotics on cell­mediated immunity. Surgery 81:692­696, 1977.
26. ALLEN, J. 1.; KAY, N. E.; and McCLAIN, E. J. Severe zinc deficiency in humans: association with a reversible T­lymphocyte dysfunction. Ann. Intern. Med. 95: 154 ­ 157, 1981.
27. CHANDRA, R. K., and Au, B. Single nutrient deficiency and cell­mediated immune responses. 1. Zinc. Am. J. Clin. Nutr. 33:736­738, 1980.
28. CHESTERS, J. K., and WILL, M. Measurement of zinc fiux through plasma in normal and endotoxin­stressed pigs and the effects of Zn supplementation during stress. Br.J. Nutr. 46:119 ­ 130, 1981.
29. DWORKIN, B. M., et al. Selenium deficiency in the acquired immunodeficiency syndrome. J. Parenter. Nutr. 10(4):405 ­ 407, 1986.
30. BRAMBILLA, G. Genotoxic effects of drug­nitrite interaction products: evidence for the need of risk assessment. Pharmacol. Res. Commun. 17(A):307321, 1985.
31. OSTERLOH, J.; et al. Butyl nitrite transformation in vitro, chemical nitrosation reactions, and mutagenesis. J. Anal. Toxicol. 8(4):164­169, 1984.
32. HAVERKOS, H. W.; PINSKY, P. F.; DROTMAN, D. P.; and BREGMAN, D. J. Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi's sarcoma. Sex. Transm. Dis. 12:203 ­ 208, 1985.
33. HAVERKOS, H. W., and DOUGHERTY, J. A. (eds.). Health Hazards of Nitrite Inhalants. National Institute on Drug Abuse (Monogr. 83), Washington, D.C., 1988.
34. LANGE, W. R., HAERTZEN, C. A.; MICKEY, J. E., et al. Nitrite inhalants: patterns of abuse in Baltimore and Washington, D.C. Am. J. Drug Akohol Abuse 14(1):29­40, 1988.
35. BOVI, P. D.; DONTI, E.; KNOWLES, D. M.; et al. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS­associated Kaposi's sarcoma. Cancer Res. 46:6333­6338, 1986.
36. JUNKER, A. K., OCHS, H. D.; CLARK, E. A., et al. Transient immune deficiency in patients with acute Epstein­Barr virus infection. Clin. Immunol. Immunopathol. 40(3):436­446, 1986.
37. CARNEY, W. P.; RUBIN, R. H.; HORRMAN, R. A.; et al. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J. Immunol. 126(6):21142116, 1981.
38. MCCHESNEY, M. B.; et al. Viruses perturb Iymphocyte functions: selected principles characterizing virus­induced immunosuppression. Ann. Rev. Immunol. 5:279 ­ 304, 1987.
39. ROUSE, B. T., and HOROHOV, D. W. Immunosuppression in viral infections. Rev. Infect. Dis. 6:850­873, 1986.
40. LUSSO, P., ENSOLT, B; MARKHAM, P. D., et al. Productive dual infection of human CD4 + T Iymphocytes by HIV­I and HHV­6. Nature 7:370­373, 1989.
41. COREY, L. C., and HOLMES, K. K. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N. Engl. J. Med. 302:435, 1980.
42. DIETZMAN, D. E.; HARNISCH, J. P.; RAY, C. G.; et al. Hepatitis B surface antigen (HBsAg) and antibody to HBsAg: prevalence in homosexual and heterosexual males. JAMA 238:2625, 1977.
43. DREW, W. L.; MINTZ, L.; MINER, R. C.; et al. Prevalence of cytomegalovirus infection in homosexual men. J. Infect. Dis. 143:188­192, 1981.
44. MARTINI, G. A.; et al. Inhibited Iymphocyte response to phytohemagglutinin (PHA) in acute infectious hepatitis and in chronic aggressive hepatitis: indirect evidence for virus persistence in chronic aggressive hepatitis? Scand. J. Gastroenterol. 7, suppl.: 39 ­ 42, 1970.
45. MELLA, B., and LANG, D. J. Leucocyte mitosis: suppression in vitro associated with acute infectious hepatitis. Science 155:80­81, 1967.
46. COULTER, H. L. AIDS and Syphilis: The Hidden Link. Berkeley, Calif. North Atlantic Books, 1987.
47. WORLD HEALTH ORGANIZATION. Consensus statements on HIV transmission. Lancet 1:396, 1989.
48. KAZAL, H. L.; SOHN, N.; CARRUSCO, J. L.; et al. The gay bowel syndrome: clinicopathological correlation in 260 cases. Ann. Clin. Lab. Sci. 6:184­192, 1976.
49. SCHMERIN, M. J; CELSTON, A.; and JONES, T. C. Amebiasis: an increasing problem among homosexuals in New York City. JAMA 238:1386, 1977.
50. MILLER, B.; STANSFIELD, S. K.; ZACK, M. M.; et al. The syndrome of unexplained generalized Iymphadenopathy in young men in New York City. JAMA 251(2):242 ­ 246, 1984.
51. BROWN, S. M.; STIMMEL, B.; TAUB, R. N.; et al. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134:1001­1006, 1974.
52. HARRIS, P. D., and GARRET, R. Susceptibility of addicts to infection and neoplasia. N. Engl. J. Med. 287(6):310, 1972.
53. SMOLAR, E. N.; PRYIMA, P. J.; and BERGER, S. Cytomegalovirus infection in a heroin addict. N.Y. State J. Med. 75(3):406, 1975.
54. FIROOZNIA, H.; SELIGER, C.; ABRAMS, R. M.; et al. Disseminated extrapulmonary tuberculosis in association with heroin addiction. Radiology 109:291­296, 1973.
55. SHAVIT, Y.; DEPAULIS, A.; MARTIN, F. C.; et al. Involvement of brain opiate receptors in the immune­suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83:7114­7117, 1986.
56. WEBER, R. J., and PERT, A. The periaqueductal gray matter mediates opiate­induced immunosuppression. Science 245:188­190, 1989.
57. WYBRAN, J.; APPELBOOM, T.; FAMAEY, J.­P.; and GOVAERTS, A. Suggestive evidence for receptors for morphine and methionine­enkephalin on normal human blood T Iymphocytes. J. Immunol. 123(1):1068­1070, 1979.
58. FALEK, A.; MADEN, J. J.; SHAFER, D. A.; and DONAHOE, R. M. Individual differences in opiate­induced alterations at the cytogenetic, DNA repair, and immunologic levels: opportunity for genetic assessment. Natl. Inst. Drug Abuse Res. Monogr. Ser. 66: 11 ­ 24, 1986.
59. DONAHOE, R. M.; NICHOLSON, J. K.; MADDEN, J. J.; et al. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T­cell Erosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41(2):254­264, 1986.
60. DONAHOE, R. M.; BUESO­RAMOS, C.; DONAHOE, F.; et al. Mechanistic implications of the findings that opiates and other drugs of abuse moderate Tcell surface receptors and antigenic markers. Ann. N.Y. Acad. Sci. 496:711721, 1987.
61. KERMAN, R. H.; FLOYD, M.; VAN BUREN, C. T., and KAHAN, B. D. Improved allograft survival of strong immune responder­high risk recipients with adjuvant antithymocyte globulin therapy. Transplantation 30:450­454,
62. GOTTLIEB, M. S. AIDS in clinical practice. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. BIGCAR, and M. MELBYE. Philadelphia. Saunders, 1984.
63. SCOTT, F. I. AIDS and HIV: questions remain. Am. Lab. 21:4, 1989.
64. OSTREA, E. M., and CHAVEZ, C. J. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J. Pediatr. 94:292­295, 1979.
65. CHANDRA, R. K. Malnutrition. In Primary and Secondary Immunodeficiency Disorders, edited by R. K. CHANDRA. Edinburgh: Churchill Livingston,
66. DOWD, P. S., and HEATLEY, R. V. The influence of undernutrition on immunity. Clin. Sci. 66:241­248, 1984.
67. BURKE, R. A., and GOOD, R. A. Pneumocystis carinii infection. Medicine 52:23­51, 1973.
68. HUGHES, W. T.; PRICE, R. A.; SISKO, F.; et al. Protein­calorie malnutrition: a host determinant for Pneumocystis carinii infection. Am. J. Dis. Child. 128:44­52, 1974.
69. BOYNE, R.; ARTHUR, J. R.; and WILSON, A. B. An in vivo and in vitro study of selenium deficiency and infection in rats. J. Comp. Pathol. 96:379­386, 1986.
70. BOYNE, R., and ARTHUR, J. R. The response of selenium­deficient mice to Candida albicans infection. J.Nutr. 116:816 ­ 822, 1986.
71. REFFETT, J. K.; SPEARS, J. W.; and BROWN, T. T. Effect of dietary selenium on the primary and secondary immune response in calves challenged with infectious bovine rhinotracheitis virus. J. Nutr. 118:229­234, 1988.
72. MITCHISON, N. A. Induction of immunological paralysis in two zones of dosage. Proc. R. Soc. Lond. 161:275 ­ 292, 1964 ­ 1965.
73. SHEARER, C. M. Immune suppression and recognition of class II (la) antigens: a possible factor in the etiology of acquired immune deficiency syndrome. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, edited by A. E. FRIEDMAN­KIEN and L. J. LAUBENSTEIN. New York: Masson, 1984.
74. MACPHERSON, B. R.; et al. Alloimmunization to public HLA antigens in multi­transfused platelet recipients. Ann. Clin. Lab. Sci. 16(1):38­44, 1986.
75. FORWELL, M. A.; et al. Transfusion­induced, Fc gamma­receptor­blocking antibodies: spectrum of cellular reactivity. J. Clin. Lab. Sci. 20(2):63­67, 1986.
76. LEDERMAN, M. M.; RATNOFF, O. D.; SCILLIAN, J. J., et al. Impaired cellmediated immunity in patients with classic hemophilia. N. Engl. J. Med. 308:79, 1983.
77. KESSLER, C. M. K.; SHULOF, R. S.; GOLDSTEIN, A.; et al. Abnormal T Iymphocyte subpopulations associated with transfusions of blood­derived products. Lancet 1:991, 1983.
78. RICKARD, K. A.; et al. Absence of AIDS in haemophiliacs in Australia treated from an entirely voluntary blood donor system. Lancet 2:50­51, 1983.
79. FISCHER, E.; LENHARD, V.; SEIFERT, P.; et al. Blood transfusion-induced suppression of cellular immunity in man. Hum. Immunol. 3: 187­194, 1980.
80. JACOBS, R. F. Frozen deglycerolized blood and transmission of EpsteinBarr virus. J. Infect. Dis. 153(4) :800, 1986.
81. KAARIAINEN, L.; KLEMOLA, E.; and PALOHEIMO, J. Rise of cytomegalovirus antibodies in an infectious­mononucleosis­like syndrome after transfusion. Br. Med. J. 1:1270 ­ 1272, 1966.
82. GASCON, P.; ZUOMBOS, N. C.; and YOUNG, N. S. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann. Intern. Med. 100(2): 173­177, 1984.
83. KAPLAN, J.; SARNAIK, S.; CITLIN, J.; and LUSHER, J. Diminished helper/ suppressor Iymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64:308­310, 1984.
84. WAYMACK, J. P.; ROBB, E.; and ALEXANDER, J. W. Effect of transfusion on immune function in a traumatized animal model. Arch. Surg. 122:935939, 1987.
85. SALVATEIRRA, O.; VINCENT, T.; AMEND, W.; et al. Deliberate donor­specific blood transfusions prior to living related renal transplantation: a new approach. Ann. Surg. 192:543­552, 1980.
86. THOMAS, F. T.; CRAVER, F. M.; FOIL, M. B.; et al. Long­term incompatible kidney survival in outbred higher primates without chronic immunosuppression. Ann. Surg. 198:370­378, 1983.
87. FRANCIS, D. M. A., and SHENTON, B. K. Blood transfusion and tumour growth: evidence from laboratory animals. Lancet 2:871, 1981.
88. BURROWS, L., and TARTTER, P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet 2:662, 1982.
89. LENHARD, V.; MAASSEN, G.; GROSSE­WILDE, H.; et al. Effect of blood transfusions on immunoregulatory mononuclear cells in prospective transplant recipients. Transplant Proc. 15: 1011 ­ 1015. 1983.
90. DODD, R. Y., and SANDIER, S. G. Transfusion­associated AIDS. In AIDS: A Basic Guide for Clinicians, edited by P. EBBESEN, R. J. BIGGAR, and M. MELSYE. Philadelphia: Saunders, 1984.
91. WARD, J. W.; BUSH, T. J., PERKINS, H. A., et al. The natural history of transfusion­associated infection with human immunodeficiency virus. N. Engl. J. Med. 321 :947­968, 1989.
92. MORGAN, J.; et al. Persistent lymphadenopathy associated with hypertransfusion in sickle­cell disease. J. Allergy Clin. Immunol. 76:869­875, 1985.
93. HOWARD, R. J., and SIMMONS, R. L. Acquired immunologic deficiencies after trauma and surgical procedures. Surg. Gynecol. Obstet. 139:771­782,
94. SLADE, M. S.; SIMMONS, R. L.; YUNIS, E.; and GREENBERG, L. J. Immunodepression after major surgery in normal patients. Surgery 78:363372, 1975.
95. BOGART, L.; BONSIGNORE, J.; and CARVALHO, A. Massive hemolysis following inhalation of volatile nitrites. Am.J. Hematol. 22:327­329, 1986.
96. SOHN, N.; WEINSTEIN, M. A.; and GONCHAR, J. Social injuries of the rectum. Am.J. Surg. 134:611 ­ 612, 1977.
97. TSUDA, T., and KAHAN, B. D. The effects of anesthesia on the immune response. In Primary and Secondary Immunodefciency Disorders, edited by R. K. CHANDRA. Edinburgh: (,hurchill Livingston, 1983.
98. WINCARD, D. W.; LANG, R.; and HUMPHREY, L. J. Effect of anesthesia on immunity. J. Surg. Res. 7:430, 1967.
99. WARD, R. Mainstream scientists confront unorthodox view of AIDS. Nature 332:574, 1988.
100. SCOTT, G. B.; FISCHL, M. A.; KLIMAS, N.; et al. Mothers of infants with acquired immunodeficiency syndrome. JAMA 253:363­366, 1985.
101. PAWHA, S.; KAPLAN, M.; FIKRIG, S.; et al. Spectrum of human T­cell Iymphotropic virus type 111 infection in children. JAMA 255:2299­2305, 198fi.
102. MINKOFF, H.; NANDA, D.: MENEZ, R.; FIKRIG, S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AlDS­related complex: follow­up of mothers, children, and subsequently born siblings. Obstel. Gynecol. 69:288­291,1987.
103. CENTERS FOR DISEASE CONTROL. Update: acquired immunodeficiency Syndrome ­ United States, 1981­1988. MMWR 38(14):229­236,1989.
104. SHANNON, K. M., and AMMANN, A. J. Acquired immune deficiency syndrome in childhood. J. Pediatr. 106:332­342,1985.
105. FRICKER, H. S., and SECAL, S. Narcotic addiction, pregnancy, and the newborn. Am.J. Dis. Child. 132:360­366,1978.
106. VARCAS, C. C.; PILDES, R. S.; VIDYASACAR, D.; and KEITH, L. G. Effect of maternal heroin addiction on 67 liveborn neonates. Clin. Pediatr. 14:751757,1975.
107. OSTREA, E. M., and CIHAVEZ, Cl. J. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J. Pediatr. 94:292­295,1979.
108. ROMERO, R.; OYARZUN, E.; and MAZOR, M. Mechanisms at work when infection triggers preterm labor. Contemp. Ob/Gyn. 29:133­150,1989.
109. MILLER, H. C., and HASSANEIN, K. Fetal malnutrition in white newborn infants: maternal factors. Pediatrics 52:504­512,1973.
110. NAEYE, R. L.; BLANC, W.; and CHERYL, P. Eftects of maternal nutrition on the human fetus. Pediatrics 52:494­503,1973.
111. HAYNES, D. C.; COLUB, M. S.; GERSHWIN, M. E.; et al. Long­term marginal zinc deprivation in rhesus monkeys. II. Effects on maternal health and fetal growth at midgestation. Am.J. Clin. Nutr. 45:1503­1513,1987.
112. MULHERN, S. A.; TAYLOR, G. L.; MAGRUDER, L. E.; and VESSEY, A. R. Deficient levels of dietary selenium suppress the antibody response in first and second generation mice. Nutr. Res. 5:201­210, 1985.
113. ATKINSON, S. A.; WHELAN, D.; WHYTE, R. K.; and LONNERDAL, B. Abnormal zinc content in human milk. Am. J. Dis. Child. 143:608­611,1979.
114. NADAL, D.; HUNZIKER, U. A.; SHUPBACH, J.; et al. Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection. Arch. Dis. Child. 64:662­669, 1989.
115. RUBIN, H. Etiology of AIDS. Science 241:1389­1390, 1988.
116. CENTERS FOR DISEASE CONTROL.. Recommendations for prevention of HIV transmission in health­care settings. MMWR 36, suppl.2S: 1S­5S, 1987.
117. CENTERS FOR DISEASE CONTROL. Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities. MMWR 37(S­4):19­22, 1988.
118. STEWART, C. J.; TYLER, J. P. P.; CUNNINGHAM, A. L.; et al. 1 transmission of human T­cell lymphotropic virus type III (HTLV­III) hy artificial insemination by donor. Lancet 2:581­583,1985.
119. AKKER, S. VAN DEN, and GOEDBLOED, F. Pneumonia caused by PneumocNsli.s carinii in a dog. Trop. Geogr. Med. 12:54 ­ 58,1960.
120. CHOISSER, R. M., and RAMSEY, E. M. Etiology of Kaposi's disease. South. Med. J. 33(4):392 ­ 396,1940.
121. MEDEARIS, D. N., JR. Mouse cytomegalovirus infection. II. Observations during prolonged infections. Am. J. Hyg. 80:103­112,1964.
122. SHELDON, W. H. Experimental pulmonary Pneumocystis carinii infection in rabbits. J. Exp. Med. 110:147,1959.
123. NlCHOLS, P. W. Opportunistic int'ections and Kaposi's sarcoma in homosexual men. N. Engl. J. Med. 306(15):934 ­ 935,1982.
124. WILLIAMS, C.; STRETTON, T. B.; and LEONARD, J. C. Cytomegalic inclusion disease and Pneumocystis carinii infection in an adult. Lancet 2:951­955, 1960.
125. GRIFFIN, B. E. Burden of proof. Nature 338:670, 1989.
126. ROOT­BERNSTEIN, R. S. Discovering. Cambridge, Mass.: Harvard Univ. Press, 1989.
127. ROOT­BERNSTEIN, R. S. Setting the stage for discovery. The Sciences, pp. 26- 34, May/June 1988.
128. ROOT­BERNSTEIN, R. S. How scientists really think. Perspect. Biol. Med. 32:472­488, 1989.
129. JONAS, S. AIDS: an alternative scenario. Congressional Record, September 15, 1988.
130. SONNABEND, J. A. AIDS: an explanation for its occurrence among homosexual men. In AIDS and Opportunistic Infections of Homosexual Men, edited by P. MA and D. ARMSTRONG. Stoneham, Mass.: Butterworth, 1989.

vedi anche: altra Bibliografia + HIV = AIDS ? NO !

- Eleni Papadopulos Eleopulos et al., 'Mother to Child Transmission of HIV and its Prevention with AZT and Nevirapine'
- Marvin Kitzerow, 'The AIDS Indictment'

- Mohammed Al-Bayati, 'Get all The Facts: HIV does not cause AIDS'

- Joan Shenton, 'Positively False; Exposing the myths around HIV and AIDS'

- Roberto Giraldo, 'AIDS and Stressors'

- Steven Epstein, 'Impure Science; AIDS, activism, and the politics of knowledge'

- Neville Hodgkinson, 'AIDS: The failure of contemporary science'

- Peter Duesberg, 'Inventing the AIDS Virus'

- Peter Duesberg (virologist), 'AIDS; Virus or drug induced?'

- Peter Duesberg, 'Infectious AIDS: Have we been misled?'

- Ian Young, 'The Stonewall Experiment; A gay psychohistory'

- Ellinor Burkett, 'The Gravest Show on Earth; America in the age of AIDS'

- Robert Willner, 'Deathly Deception'

- Robert Root-Bernstein, 'Rethinking AIDS; The tragic cost of premature consensus'

- John Lauritsen & Ian Young (editors), 'The AIDS Cult: Essays on the gay health crisis'
- John Lauritsen, 'The AIDS War; Propaganda, profiteering and genocide from the medical-industrial complex'

- John Lauritsen, 'Poison by Prescription; The AZT story'

- Bruce Nussbaum, 'Good Intentions; How big business and the medical establishment are corrupting the fight against AIDS'

- Jad Adams, 'AIDS; The HIV myth'

- Jon Rappoport, 'AIDS Inc.; Scandal of the century'

Most recent releases are at left of the shelf, or top of the list.

"Il paziente malato di Aids NON muore a causa del virus dell'HIV ma per alterazioni dell'assorbimento intestinale  e quindi per ipoalimentazione  (malNutrizione), dovuta a una grave micosi." (By Dott. Gerhard Orth, Leuthkirch)
vedi: Aids its the Bacteria stupid - PDF + Aids its really caused by a virus ?